This company has been marked as potentially delisted and may not be actively trading. Histogenics (HSGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HSGX vs. APT, MLSS, LGMK, CYH, SY, CMPX, OLMA, DCTH, RXST, and SENSShould you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Alpha Pro Tech (APT), Milestone Scientific (MLSS), LogicMark (LGMK), Community Health Systems (CYH), So-Young International (SY), Compass Therapeutics (CMPX), Olema Pharmaceuticals (OLMA), Delcath Systems (DCTH), RxSight (RXST), and Senseonics (SENS). Histogenics vs. Its Competitors Alpha Pro Tech Milestone Scientific LogicMark Community Health Systems So-Young International Compass Therapeutics Olema Pharmaceuticals Delcath Systems RxSight Senseonics Alpha Pro Tech (NYSE:APT) and Histogenics (NASDAQ:HSGX) are both small-cap surgical appliances & supplies industry companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership. Which has more risk & volatility, APT or HSGX? Alpha Pro Tech has a beta of 0.24, suggesting that its share price is 76% less volatile than the S&P 500. Comparatively, Histogenics has a beta of 3.1, suggesting that its share price is 210% more volatile than the S&P 500. Does the media prefer APT or HSGX? In the previous week, Alpha Pro Tech had 1 more articles in the media than Histogenics. MarketBeat recorded 1 mentions for Alpha Pro Tech and 0 mentions for Histogenics. Alpha Pro Tech's average media sentiment score of 0.00 equaled Histogenics'average media sentiment score. Company Overall Sentiment Alpha Pro Tech Neutral Histogenics Neutral Which has better valuation and earnings, APT or HSGX? Alpha Pro Tech has higher revenue and earnings than Histogenics. Histogenics is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Pro Tech$58.56M0.86$4.19M$0.3414.15HistogenicsN/AN/A-$8.64M-$0.79-1.33 Is APT or HSGX more profitable? Alpha Pro Tech has a net margin of 6.99% compared to Histogenics' net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Histogenics' return on equity.Company Net Margins Return on Equity Return on Assets Alpha Pro Tech6.99% 6.70% 5.76% Histogenics N/A -34.96%18.40% Do insiders & institutionals believe in APT or HSGX? 22.7% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 40.4% of Histogenics shares are owned by institutional investors. 15.0% of Alpha Pro Tech shares are owned by company insiders. Comparatively, 19.7% of Histogenics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryAlpha Pro Tech beats Histogenics on 7 of the 11 factors compared between the two stocks. Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSGX vs. The Competition Export to ExcelMetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$99.33M$26.39M$5.76B$9.75BDividend YieldN/AN/A3.95%4.02%P/E Ratio-1.3313.0531.4526.36Price / SalesN/A2.05431.04155.09Price / CashN/A12.8037.7559.42Price / Book-105.002.0810.536.57Net Income-$8.64M-$5.31M$3.28B$265.92M Histogenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSGXHistogenicsN/A$1.05+1.0%N/A-21.8%$99.33MN/A-1.3349APTAlpha Pro Tech0.7013 of 5 stars$4.62+0.4%N/A-21.4%$48.39M$58.56M12.49120News CoverageMLSSMilestone Scientific2.3721 of 5 stars$0.60-0.3%$1.25+109.0%-36.9%$47.14M$9.08M-8.5430LGMKLogicMark0.4497 of 5 stars$0.00-2.6%N/A-99.9%$2.13M$9.88M0.0020Gap UpCYHCommunity Health Systems4.3534 of 5 stars$2.72+0.6%$3.58+31.7%-48.7%$378.32M$12.63B-1.8260,000Gap DownSYSo-Young International1.9556 of 5 stars$4.06+9.4%$5.50+35.5%-70.4%$376.33M$200.94M-4.671,800CMPXCompass Therapeutics2.207 of 5 stars$2.78+2.2%$12.89+363.6%+193.3%$376.13M$850K-6.1820OLMAOlema Pharmaceuticals1.9378 of 5 stars$5.45+0.4%$24.00+340.4%-51.7%$372.68MN/A-2.7570News CoverageDCTHDelcath Systems3.0147 of 5 stars$10.33-2.2%$24.50+137.2%+2.3%$369.40M$37.21M206.6060Positive NewsRXSTRxSight0.9591 of 5 stars$8.45-4.1%$10.00+18.3%-83.2%$360.47M$139.93M-10.56220Trending NewsSENSSenseonics2.2277 of 5 stars$0.44-3.2%$1.55+250.7%+22.7%$360.09M$25.47M-3.4090News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies APT Competitors MLSS Competitors LGMK Competitors CYH Competitors SY Competitors CMPX Competitors OLMA Competitors DCTH Competitors RXST Competitors SENS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSGX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access